Local view for "http://purl.org/linkedpolitics/eu/plenary/2009-03-24-Speech-2-267"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2009-03-24"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20090324.26.2-267"2
lpv:hasSubsequent	lp_eu:2009-03-24-Speech-2-2682
lpv:speaker	lp:Lydia Schenardi2
lpv:spokenAs	unknown; Front national (2004-07-20--2009-07-13)3 member; ITRE (2007-01-31--2009-07-13)3 member; FEMM (2007-01-31--2009-07-13)3 member; Delegation for relations with the Maghreb countries and the Arab Maghreb Union (including Libya) (2007-03-14--2009-07-13)3 substitute; Delegation for relations with India (2007-03-15--2009-07-13)3 substitute; AGRI (2007-01-31--2009-07-13)3 member; NA (2007-11-14--2009-07-13)3
lpv:translated text	". Since the introduction of nanoparticles in cosmetic products, as well as the fact that the cosmetics sector features among the biggest victims of industrial counterfeiting, it is important to have clear means of control, particularly for identifying counterfeit cosmetics, which do not therefore meet legal requirements. Some products in fact warrant particular attention, especially cosmetics used around the eyes, on the mucous membrane, on damaged skin, for children or those with a weakened immune system. Clearly a particular focus is needed on local toxicity evaluation, skin and eye irritation, skin sensitisation, and photo-induced toxicity in the case of UV absorption. In addition, the fight against counterfeiting using these controls is vital for public health and environmental impact, but also for competitiveness. We therefore support this report, but new tests should not be performed on finished products if known information on the ingredients they contain proves compliant with legislation."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph